Adis Journals
Browse
summary slide.png (122.23 kB)

One-Year of Dapaglifozin Add-On Therapy Ameliorates Surrogate Indexes of Insulin Resistance and Adiposity in Patients with Type 2 Diabetes Mellitus

Download (122.23 kB)
media
posted on 2021-04-14, 14:47 authored by Adis journals on behalf of, Stefano Radellini, Enrica Vigneri, Valentina Guarnotta, Felicia Panto, Carla Giordano

Article full text


The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2021.

History

Usage metrics

    Diabetes Therapy

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC